News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Based in the US, Suzanne Lukac joins the CluePoints from Merck, where she was the director for clinical operations and global RBM implementation.
In her new role, lukac will lead the development and delivery of consultative services covering RBM methodology. She also will work with the product team, advising on enhancements to CluePoints’ RBM platform.
“I am looking forward to providing subject matter expertise to our current and new clients in the area of risk- based quality management,” Lukac told us.
“Having led adoption of risk based monitoring (RBM) at a large pharmaceutical company and collaborating with other companies as part of TransCelerate, I realize the challenges and pain points that many of our clients are experiencing,” she said.
“Using this knowledge, I hope to provide support to our clients not only to help build a solid RBM foundation, but also to continue to improve and streamline their processes as they become more experienced,” she added. “I am also looking forward to liaising with clients to help improve our partnerships and product.”